Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) represents a challenge clinically due to the lack of actionable targets coupled with an aggressive disease course and a worse prognosis compared to patients with other breast cancer subtypes. This book covers aspects of TNBC ranging from epidemiology, biology, molecular classification, to currently available and potentially new therapeutics options for TNBC. This book includes a range of recommended resources, including recent reviews, schematic illustrations, and information for patients with TNBC.